Go to:
Logótipo
Você está em: Start > Publications > View > KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program
Map of Premises
Principal
Publication

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program

Title
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program
Type
Another Publication in an International Scientific Journal
Year
2008
Authors
van Krieken, JHJM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Jung, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Kirchner, T
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Bosman, FT
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Quirke, P
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Flejou, JF
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Hansen, TP
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
de Hertogh, G
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Jares, P
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Langner, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Hoefler, G
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ligtenberg, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Tiniakos, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Tejpar, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Bevilacqua, G
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ensari, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: Virchows ArchivImported from Authenticus Search for Journal Publications
Vol. 453 No. 5
Pages: 417-431
ISSN: 0945-6317
Publisher: Springer Nature
Other information
Authenticus ID: P-003-VDP
Abstract (EN): Novel therapeutic agents targeting the epidermal growth factor receptor (EGFR) have improved outcomes for patients with colorectal carcinoma. However, these therapies are effective only in a subset of patients. Activating mutations in the KRAS gene are found in 30-40% of colorectal tumors and are associated with poor response to anti-EGFR therapies. Thus, KRAS mutation status can predict which patient may or may not benefit from anti-EGFR therapy. Although many diagnostic tools have been developed for KRAS mutation analysis, validated methods and standardized testing procedures are lacking. This poses a challenge for the optimal use of anti-EGFR therapies in the management of colorectal carcinoma. Here we review the molecular basis of EGFR-targeted therapies and the resistance to treatment conferred by KRAS mutations. We also present guideline recommendations and a proposal for a European quality assurance program to help ensure accuracy and proficiency in KRAS mutation testing across the European Union.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 15
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: Proposal for an European quality assurance program (Virchows Archiv DOI: 10.1007/s00428-008-0665-y) (2009)
Other Publications
Van Krieken, JHJM; Jung, A; Kirchner, T; Carneiro F; Seruca, R; Bosman, FT; Quirke, P; Flejou, JF; Hansen, TP; De Hertogh, G; Jares, P; Langner, C; Hoefler, G; Ligtenberg, M; Tiniakos, D; Tejpar, S; Bevilacqua, G; Ensari, A

Of the same journal

Warthin's tumour (2006)
Another Publication in an International Scientific Journal
Sobrinho Simoes, M; Maximo, V
The gastric disease of Napoleon Bonaparte: brief report for the bicentenary of Napoleon's death on St. Helena in 1821 (2021)
Another Publication in an International Scientific Journal
Lugli, A; Carneiro F; Dawson, H; Flejou, JF; Kirsch, R; van der Post, RS; Vieth, M; Svrcek, M
Telomerase promoter mutations in cancer: an emerging molecular biomarker? (2014)
Another Publication in an International Scientific Journal
Joao Vinagre; Vasco Pinto; Ricardo Celestino; Marta Reis; Helena Populo; Paula Boaventura; Miguel Melo; Telmo Catarino; Jorge Lima; Lopes, JM; Valdemar Maximo; Manuel Sobrinho Simoes; Paula Soares
Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology (2024)
Another Publication in an International Scientific Journal
Ilié, M; Lake, V; de Alava, E; Bonin, S; Chlebowski, S; Delort, A; Dequeker, E; Al-Dieri, R; Diepstra, A; Carpén, O; Eloy, C; Fassina, A; Fend, F; Fernandez, PL; Gorkiewicz, G; Heeke, S; Henrique, R; Hoefler, G; Huertas, P; Hummel, M...(mais 9 authors)
Sporadic, syndromic, and Zollinger-Ellison syndrome associated fundic gland polyps consistently express cytokeratin 7 (2002)
Another Publication in an International Scientific Journal
Declich, P; Tavani, E; Bellone, S; Porcellati, M; Raimondi, D; Grassini, R; Carneiro F; Bordi, C

See all (89)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-28 at 21:29:12 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book